20/20 Biolabs, Inc. (AIDX)
Data as of , from SEC Form 4 filings.
See up to 3 months of AIDX. The 7-day demo opens the 1M and 3M ranges and puts AIDX on your watchlist.
Start 7-day demoLatest AIDX insider trades
About 20/20 Biolabs, Inc. (AIDX)
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
- ROCKVILLE, MD
- 14
- 2026
- XNAS
AIDX Form 4 activity by transaction type, last 90 days
No Form 4 activity for AIDX in the last 90 days.
AIDX insider transactions (Form 4)
137 Form 4 filings on record, the earliest from Feb 23, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Alan B. Bergman - Officer | Grant or award | Stock Option | 100,000 | $0.00 | - | |
| Jiming Zhou - Officer | Grant or award | Stock Option | 150,000 | $0.00 | - | |
| Jonathan M. Cohen - Officer | Grant or award | Stock Option | 352,936 | $0.00 | - | |
| John Woodson Rollins - Director | Other | Common Stock | 13,029 | $0.00 | - | |
| John Woodson Rollins - Director | Other | Common Stock | 6,135 | $0.00 | - | |
| John Woodson Rollins - Director | Other | Series A Preferred Stock | 13,029 | - footnote F1 | - | |
| John Woodson Rollins - Director | Other | Series A-2 Preferred Stock | 6,135 | - footnote F2 | - | |
| ||||||
| Michael A. Ross - Director | Other | Common Stock | 31 | $0.00 | - | |
| Michael A. Ross - Director | Other | Series A-2 Preferred Stock | 31 | - footnote F1 | - | |
| ||||||
| John G. Compton - Director | Other | Common Stock | 7,669 | $0.00 | - | |
| John G. Compton - Director | Other | Series A-2 Preferred Stock | 7,669 | - footnote F1 | - | |
| ||||||
| Richard M. Cohen - Director | Other | Common Stock | 7,700 | $0.00 | - | |
| Richard M. Cohen - Director | Other | Series A-2 Preferred Stock | 7,700 | - footnote F1 | - | |
| ||||||
AIDX insider trading FAQ
What is the latest insider trade for AIDX?
20/20 Biolabs, Inc. (AIDX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-06. The full record for AIDX runs to 7 Form 4 filings, the earliest from 2026-02-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AIDX stock?
No insider purchases of AIDX were filed in the last 90 days.
How many insiders are selling AIDX stock?
No insider sales of AIDX were filed in the last 90 days.
Where can I see AIDX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AIDX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
7The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Alan B. Bergman view on EDGAR
- - Jiming Zhou view on EDGAR
- - Jonathan M. Cohen view on EDGAR
- - John Woodson Rollins view on EDGAR
- - Michael A. Ross view on EDGAR
- - John G. Compton view on EDGAR
- - Richard M. Cohen view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AIDX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AIDX with a 7-day demo
- AIDX on your watchlist
- Every AIDX Form 4 filing on record
- Up to 3 months of AIDX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
